Site Search
Displaying results 11 - 20 of 573
Resource | Publications,
Achieving validation of elimination of mother-to-child transmission (EMTCT) of HIV, syphilis and hepatitis B virus (HBV) is a tremendous accomplishment, requiring health ministry–led accountability, rigorous data analysis, intensive programme assessment and multilevel collaboration. This governance guidance outlines the standardized structures and processes used to validate EMTCT of HIV, syphilis and HBV at the national, regional and global levels. Replacing an earlier version published in June 2020 addressing EMTCT of HIV and syphilis, this revised governance document aligns with new information in the Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis, and hepatitis B virus, in which WHO sets criteria for validation of triple elimination.
Resource | Publications,
This policy brief focuses on the new recommendations on treatment of adolescents and children aged 3 years or older with chronic hepatitis C virus (HCV) infection.
Resource | Publications,
This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and task-sharing, in addition to the use of point-of-care (POC) HCV viral load assays and reflex viral load testing.
Resource | Publications,
The 2022 Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response to HIV, viral hepatitis and sexually transmitted infections (STIs) for 5 key populations (men who have sex with men, sex workers, people in prisons and other closed settings, people who inject drugs and trans and gender diverse people).
The guidelines present and discuss new recommendations and consolidate a range of recommendations and guidance from current WHO guidelines which are summarised here in this policy brief.
Resource | Guidelines,
The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings). They present and discuss new recommendations and consolidate a range of recommendations and guidance from current WHO guidelines.
Particularly for key populations, social, legal, structural and other contextual factors both increase vulnerability to HIV, viral hepatitis and STIs and obstruct access to health and other essential services. These guidelines highlight the critical importance of addressing structural barriers in all settings as a priority.
Resource | Publications,
amfAR’s TREAT Asia program and three partner organizations initiated two Community Treatment Observatories (CTOs) to assess availability, accessibility, acceptability and quality of services for HIV and Hepatitis C (HCV) in India and Indonesia. It is hoped that the resulting analysis, available here, will help inform and advance advocacy priorities aimed at improving and expanding access to HIV and HCV services in the two countries.
Resource | Guidelines,
These guidelines focus on the collection and use of person-centred data across the HIV cascade – from prevention, testing and treatment to longer-term health care – building upon 2017 and 2020 strategic information guidelines. The updated guidelines present a standard minimum dataset, priority indicators and recommendations to strengthen data use across HIV prevention, testing and treatment, and linkages to services for sexually transmitted infections, viral hepatitis, tuberculosis and cervical cancer. The guidelines also cover the use of routinely collected data for HIV surveillance (including measurement of HIV prevalence and incidence) and emphasize the use of data from different sources to gain a better picture of epidemiologic trends.
Resource | Presentations,
Browse and view tables, charts and graphs illustrating data on antiretroviral therapy (ART), prevention of mother-to-child transmission (PMTCT), and TB-HIV Co-Treatment.
Resource | Publications,
This report is a compilation of data provided or published by countries in the region on their national situation relating to compulsory drug treatment and rehabilitation. It also serves as a mechanism for monitoring progress towards meeting commitments agreed by countries in 2015 in Manila to phase out compulsory treatment and rehabilitation and to scale up the implementation of voluntary community-based treatment and services.
Resource | Publications,
By the end of 2020, over 25 million people were receiving antiretroviral therapy (ART) in low- and middle-income countries.
This report aims to provide countries and suppliers with estimates of the global market for antiretroviral (ARV) medicines in low- and middle-income countries for 2021–2025. The report includes estimates of the global demand for active pharmaceutical ingredients (APIs) and ARV formulations for adults receiving first-line treatment to enable suppliers to plan adjustments to their manufacturing capacity and processes.